| Completed | A Single-center, Open-label, Study Evaluating Safety and Pharmacokinetics of Single Doses of Zidebactam-Cefepi PHA1A | Phase 1 | 2025-01-21 |
| Unknown | Study of Cefepime-tazobactam (FEP-TAZ) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis ( Complicated Urinary Tract Infection, Acute Pyelonephritis | Phase 3 | 2024-01-01 |
| Completed | Study of Cefepime-zidebactam (FEP-ZID) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis ( Complicated Urinary Tract Infection, Acute Pyelonephritis | Phase 3 | 2022-08-28 |
| Completed | Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Intravenous Nafithromycin Healthy | Phase 1 | 2019-06-18 |
| Completed | To Investigate the Multiple Dose Safety, Tolerability and Pharmacokinetics of WCK 4282 (FEP-TAZ) Antibiotics Causing Adverse Effects in Therapeutic Use | Phase 1 | 2018-03-23 |
| Completed | Study of the Metabolism and Excretion of Zidebactam (WCK 5107) Following a Single Intravenous Infusion. Healthy Subjects (HS) | Phase 1 | 2017-12-13 |
| Completed | Comparative Study of Levonadifloxacin (IV and Oral) With Linezolid (IV and Oral) in Acute Bacterial Skin and S Acute Bacterial Skin and Skin Structure Infections | Phase 3 | 2017-08-25 |
| Completed | Plasma and Intrapulmonary Concentrations Study of WCK 5222 PHA1A | Phase 1 | 2017-03-31 |
| Completed | Evaluate the Effect of WCK 5222 on the QT/QTc Interval in Healthy Volunteers QT/QTc Interval in Healthy Volunteers | Phase 1 | 2017-02-09 |
| Completed | Phase II Study of Oral Nafithromycin in CABP Community-Acquired Bacterial Pneumonia (CABP) | Phase 2 | 2016-11-18 |
| Completed | To Investigate The Pharmacokinetics Of Intravenous WCK 5222 (FEP-ZID) In Patients With Renal Impairment Renal Impairment | Phase 1 | 2016-10-25 |
| Completed | A Phase 1 Pharmacokinetic Study of Single-Ascending Doses of Intravenous Nafithromycin in Healthy Adult Subjec Healthy Volunteers | Phase 1 | 2016-04-25 |
| Completed | A Single-dose Study to Investigate the Pharmacokinetics of Intravenous FEP-TAZ in Patients With Renal Impairme Renal Impairment | Phase 1 | 2016-03-01 |
| Completed | MED Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous WCK 5222 (Zidebactam and Ce Serious Gram-negative Infections | Phase 1 | 2016-03-01 |
| Completed | MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous Zidebactam in Healthy Adult Healthy Subjects | Phase 1 | 2016-02-01 |
| Completed | Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WCK 5107 Alone and in Combination With Cef Healthy | Phase 1 | 2015-08-01 |
| Completed | Study to Determine and Compare Plasma and Intrapulmonary Concentrations of WCK 4873 in Healthy Adult Human Sub Healthy | Phase 1 | 2015-04-01 |
| Completed | Pharmacokinetics of WCK 2349 In Patients With Hepatic Impairment Hepatic Impairment | Phase 1 | 2014-09-01 |
| Completed | Study to Determine and Compare Plasma and Intrapulmonary Pharmacokinetics of WCK 2349 in Healthy Adult Human S Intrapulmonary Pharmacokinetics of WCK 2349 | Phase 1 | 2014-09-01 |
| Completed | Study to Evaluate the Effect Of WCK 2349 on the QT/QTc Interval in Health Volunteers Qt Interval, Variation in | Phase 1 | 2014-08-01 |
| Completed | Evaluate The Safety, Tolerability and Pharmacokinetics Of Multiple Ascending Oral Doses Of WCK 4873 In Healthy Healthy | Phase 1 | 2013-08-20 |
| Completed | Phase I, Open Label,Crossover Food-Effect and Absolute Bioavailability Study of WCK2349 and WCK771 in Healthy Effect of Food | Phase 1 | 2013-06-01 |
| Completed | The Safety, Tolerability And Pharmacokinetics Of Single Ascending Doses And The Effect Of Food On Oral WCK 487 Healthy | Phase 1 | 2013-03-14 |
| Withdrawn | Immunogenicity Study of Wockhardt's Insulin Lispro/Lispro Mix Basal Bolus Regimen in Type 1 Diabetics Type I Diabetes | Phase 3 | 2012-02-01 |
| Completed | Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Intravenous WCK Bioavailability | Phase 1 | 2011-12-01 |
| Withdrawn | Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Lispro (Listro™) With Humalog® in Healthy Sub Bioequivalence in Healthy Subjects | Phase 1 | 2011-11-01 |
| Withdrawn | Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Mixture Listro Mix 75/25® and Humalog Mix75/2 Bioequivalence in Healthy Subjects | Phase 1 | 2011-11-01 |
| Completed | Comparative Glucose Clamp Study of Wockhardt's Recombinant Insulin Analog Glargine(Glaritus) With Lantus in T1 Type1 Diabetes | Phase 1 | 2011-06-01 |
| Completed | Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Oral WCK 2349 Pharmacokinetics | Phase 1 | 2011-03-17 |
| Terminated | Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics Type I Diabetes | Phase 3 | 2011-03-01 |
| Completed | Comparative Wockhardt's Glucose Clamp Study-Human Isophane Susp 30IU/ml/70IU/ml With Novolin70/30, in Healthy Diabetes Mellitus | Phase 1 | 2011-01-01 |
| Completed | Comparative Glucose Clamp Study of Wockhardt's Human Isophane Insulin With Novolin N,in Healthy Subjects Diabetes | Phase 1 | 2010-09-01 |
| Completed | Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Type 1 Dia Diabetes | Phase 1 | 2008-08-01 |
| Completed | Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Healthy Su Diabetes | Phase 1 | 2008-07-01 |
| Completed | Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Novolin R, in Healthy S Diabetes Mellitus | Phase 1 | 2008-01-01 |
| Withdrawn | Immunogenicity Safety Study of Wockhardt's Recombinant Insulin Analogue in Type 1 Diabetic Patients Type I Diabetes | Phase 3 | — |
| Withdrawn | Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Listro Mix 50/50® and Humalog Mix50/50® in He Bioequivalence in Healthy Subjects | Phase 1 | — |